Parametric Portfolio Associates’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-6,057
Closed -$362K 4007
2020
Q2
$362K Sell
6,057
-14,466
-70% -$894K ﹤0.01% 3394
2020
Q1
$1.22M Sell
20,523
-1,045
-5% -$60.9K ﹤0.01% 2689
2019
Q4
$1.18M Buy
+21,568
New +$805K ﹤0.01% 2973

Other funds holding PRNB

Parametric Portfolio Associates's PRNB Position: Q3 2020 in Review

Parametric Portfolio Associates sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 6,057 shares — an estimated $362K sold.

Parametric Portfolio Associates first reported a position in PRNB in Q4 2019 and held it in 3 quarters. The position peaked at $1.22M in Q1 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Parametric Portfolio Associates reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Parametric Portfolio Associates sold 6,057 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $362K.
  • Parametric Portfolio Associates first reported a position in Principia Biopharma Inc. Common Stock in Q4 2019 and held it in 3 quarters.
  • Parametric Portfolio Associates's Principia Biopharma Inc. Common Stock position peaked at $1.22M in Q1 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Parametric Portfolio Associates's 13F filing for Q3 2020, filed 12 Nov 2020.